Cargando…

Detailed methylation map of LINE‐1 5′‐promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity

BACKGROUND: Long interspersed nuclear elements (LINE‐1) sequences constitute a substantial portion of the human genome, and their methylation often correlating with global genomic methylation. Previous studies have highlighted the feasibility of using LINE‐1 methylation to discriminate tumors from h...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Amit, Jamil, Muhammad A., Nuesgen, Nicole, Dauksa, Albertas, Gulbinas, Antanas, Schulz, Wolfgang A., Oldenburg, Johannes, El‐Maarri, Osman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503062/
https://www.ncbi.nlm.nih.gov/pubmed/30955237
http://dx.doi.org/10.1002/mgg3.601
_version_ 1783416345348538368
author Sharma, Amit
Jamil, Muhammad A.
Nuesgen, Nicole
Dauksa, Albertas
Gulbinas, Antanas
Schulz, Wolfgang A.
Oldenburg, Johannes
El‐Maarri, Osman
author_facet Sharma, Amit
Jamil, Muhammad A.
Nuesgen, Nicole
Dauksa, Albertas
Gulbinas, Antanas
Schulz, Wolfgang A.
Oldenburg, Johannes
El‐Maarri, Osman
author_sort Sharma, Amit
collection PubMed
description BACKGROUND: Long interspersed nuclear elements (LINE‐1) sequences constitute a substantial portion of the human genome, and their methylation often correlating with global genomic methylation. Previous studies have highlighted the feasibility of using LINE‐1 methylation to discriminate tumors from healthy tissues. However, most studies are based on only a few specific LINE‐1 CpG sites. METHODS: Herein, we have performed a systematic fine‐scale analysis of methylation at 14 CpGs located in the 5′‐region of consensus LINE‐1, in bladder, colon, prostate, and gastric tumor tissues using a global degenerate approach. RESULTS: Our results reveal variable methylation levels between different CpGs, as well as some tissue‐specific differences. Trends toward hypomethylation were observed in all tumors types to certain degrees, showing statistically significance in bladder and prostate tumors. Our data points toward the presence of unique LINE‐1 DNA methylation patterns for each tumor type and tissue, indicating that not the same CpGs will be informative for testing in all tumor types. CONCLUSION: This study provides an accurate guide that will help to design further assays that could avoid artifacts and explain the variability of obtained LINE‐1 methylation values between different studies.
format Online
Article
Text
id pubmed-6503062
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65030622019-05-10 Detailed methylation map of LINE‐1 5′‐promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity Sharma, Amit Jamil, Muhammad A. Nuesgen, Nicole Dauksa, Albertas Gulbinas, Antanas Schulz, Wolfgang A. Oldenburg, Johannes El‐Maarri, Osman Mol Genet Genomic Med Original Articles BACKGROUND: Long interspersed nuclear elements (LINE‐1) sequences constitute a substantial portion of the human genome, and their methylation often correlating with global genomic methylation. Previous studies have highlighted the feasibility of using LINE‐1 methylation to discriminate tumors from healthy tissues. However, most studies are based on only a few specific LINE‐1 CpG sites. METHODS: Herein, we have performed a systematic fine‐scale analysis of methylation at 14 CpGs located in the 5′‐region of consensus LINE‐1, in bladder, colon, prostate, and gastric tumor tissues using a global degenerate approach. RESULTS: Our results reveal variable methylation levels between different CpGs, as well as some tissue‐specific differences. Trends toward hypomethylation were observed in all tumors types to certain degrees, showing statistically significance in bladder and prostate tumors. Our data points toward the presence of unique LINE‐1 DNA methylation patterns for each tumor type and tissue, indicating that not the same CpGs will be informative for testing in all tumor types. CONCLUSION: This study provides an accurate guide that will help to design further assays that could avoid artifacts and explain the variability of obtained LINE‐1 methylation values between different studies. John Wiley and Sons Inc. 2019-04-06 /pmc/articles/PMC6503062/ /pubmed/30955237 http://dx.doi.org/10.1002/mgg3.601 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Sharma, Amit
Jamil, Muhammad A.
Nuesgen, Nicole
Dauksa, Albertas
Gulbinas, Antanas
Schulz, Wolfgang A.
Oldenburg, Johannes
El‐Maarri, Osman
Detailed methylation map of LINE‐1 5′‐promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity
title Detailed methylation map of LINE‐1 5′‐promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity
title_full Detailed methylation map of LINE‐1 5′‐promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity
title_fullStr Detailed methylation map of LINE‐1 5′‐promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity
title_full_unstemmed Detailed methylation map of LINE‐1 5′‐promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity
title_short Detailed methylation map of LINE‐1 5′‐promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity
title_sort detailed methylation map of line‐1 5′‐promoter region reveals hypomethylated cpg hotspots associated with tumor tissue specificity
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503062/
https://www.ncbi.nlm.nih.gov/pubmed/30955237
http://dx.doi.org/10.1002/mgg3.601
work_keys_str_mv AT sharmaamit detailedmethylationmapofline15promoterregionrevealshypomethylatedcpghotspotsassociatedwithtumortissuespecificity
AT jamilmuhammada detailedmethylationmapofline15promoterregionrevealshypomethylatedcpghotspotsassociatedwithtumortissuespecificity
AT nuesgennicole detailedmethylationmapofline15promoterregionrevealshypomethylatedcpghotspotsassociatedwithtumortissuespecificity
AT dauksaalbertas detailedmethylationmapofline15promoterregionrevealshypomethylatedcpghotspotsassociatedwithtumortissuespecificity
AT gulbinasantanas detailedmethylationmapofline15promoterregionrevealshypomethylatedcpghotspotsassociatedwithtumortissuespecificity
AT schulzwolfganga detailedmethylationmapofline15promoterregionrevealshypomethylatedcpghotspotsassociatedwithtumortissuespecificity
AT oldenburgjohannes detailedmethylationmapofline15promoterregionrevealshypomethylatedcpghotspotsassociatedwithtumortissuespecificity
AT elmaarriosman detailedmethylationmapofline15promoterregionrevealshypomethylatedcpghotspotsassociatedwithtumortissuespecificity